(19)
(11) EP 3 709 978 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
31.05.2023 Bulletin 2023/22

(45) Mention of the grant of the patent:
05.04.2023 Bulletin 2023/14

(21) Application number: 18803675.0

(22) Date of filing: 16.11.2018
(51) International Patent Classification (IPC): 
A61K 9/48(2006.01)
A61K 35/745(2015.01)
A61P 1/04(2006.01)
A61K 35/741(2015.01)
 A61K 9/19(2006.01)
A23L 33/135(2016.01)
A61P 43/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/19; A61K 9/4816; A61K 9/4891; A61K 35/741; A23L 33/135; A61P 1/04; A61P 43/00; Y02A 50/30
(86) International application number:
PCT/EP2018/081650
(87) International publication number:
WO 2019/097030 (23.05.2019 Gazette 2019/21)

(54)

PHARMACEUTICAL ORAL FORMULATION COMPRISING BACTERIA

ORALE PHARMAZEUTISCHE FORMULIERUNG ENTHALTEND BAKTERIEN

FORMULATION PHARMACEUTIQUE ORALE COMPRENANT DES BACTÉRIES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.11.2017 EP 17306602

(43) Date of publication of application:
23.09.2020 Bulletin 2020/39

(73) Proprietors:
  • Maat Pharma
    69007 Lyon (FR)
  • Biocodex
    94250 Gentilly (FR)

(72) Inventors:
  • SCHWINTNER, Carole
    69007 Lyon (FR)
  • ROBIN, Marianne
    69007 Lyon (FR)
  • DUBUISSON, Jean-François
    69007 Lyon (FR)
  • AFFAGARD, Hervé
    69007 Lyon (FR)
  • MICHENET, Cédric
    60000 Beauvais (FR)
  • BARDY, Amandine
    28000 Chartres (FR)

(74) Representative: Santarelli 
Tour Trinity 1 bis Esplanade de la Défense
92035 Paris La Défense Cedex
92035 Paris La Défense Cedex (FR)


(56) References cited: : 
WO-A1-2014/152338
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).